Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis von O'Connor, Paul, Wolinsky, Jerry S, Confavreux, Christian, Comi, Giancarlo, Kappos, Ludwig, Olsson, Tomas P, Benzerdjeb, Hadj, Truffinet, Philippe, Wang, Lin, Miller, Aaron, Freedman, Mark S

Volltext

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta von Wynn, Daniel, MD, Kaufman, Michael, MD, Montalban, Xavier, MD, Vollmer, Timothy, MD, Simon, Jack, MD, Elkins, Jacob, MD, O'Neill, Gilmore, MD, Neyer, Lauri, PhD, Sheridan, James, PhD, Wang, Chungchi, PhD, Fong, Alice, PharmD, Rose, John W, MD

Volltext

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials von Goodman, Andrew D, Bethoux, Francois, Brown, Theodore R, Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N, Henney, Herbert R, Blight, Andrew R, Agius, M, Arnason, BGW, Bethoux, FA, Bever, CT, Bowen, JD, Brown, TR, Dietrich, DW, Edwards, K, Freedman, MS, Freedman, M, Kachuck, NJ, Kaufman, MD, Keilson, M, Khan, O, Krupp, LB, Leist, TP, Lindsey, JW, Lublin, FD, Mass, MK, Mattson, D, McGowan, D, Naismith, R, O’Connell, C, Oger, JJ, Panitch, H, Picone, MA, Rammohan, KW, Schapiro, RT, Schwid, SR, Scott, T, Short, C, Thrower, BW, Vollmer, TL, Camac, A, Cooper, JA, Chumley, WF, Cross, A, Dunnigan, RT, Gitt, JS, Hillen, M, Jeffrey, DR, Khatri, BO, Kresa-Reahl, K, Moon, S, Preiningerova, J, Tullman, M, Weinstock-Guttman, B, Wynn, DR

Volltext

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial von Kappos, Ludwig, Edan, Gilles, Freedman, Mark S, Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J, Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria

Volltext

GLANCE : Results of a phase 2, randomized, double-blind, placebo-controlled study von GOODMAN, A. D, ROSSMAN, H, PANZARA, M. A, SANDROCK, A. W, BAR-OR, A, MILLER, A, MILLER, D. H, SCHMIERER, K, LUBLIN, F, KHAN, O, BORMANN, N. M, YANG, M

Volltext

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS von FREEDMAN, M. S, BAR-OR, A, FERENCZI, L, VERCO, T, OGER, J, TRABOULSEE, A, PATRY, D, YOUNG, C, OLSSON, T, LI, D, HARTUNG, H.-P, KRANTZ, M

Volltext

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study von OʼConnor, Paul, Comi, Giancarlo, Freedman, Mark S, Miller, Aaron E, Kappos, Ludwig, Bouchard, Jean-Pierre, Lebrun-Frenay, Christine, Mares, Jan, Benamor, Myriam, Thangavelu, Karthinathan, Liang, Jinjun, Truffinet, Philippe, Lawson, Victoria J, Wolinsky, Jerry S

Volltext

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT... von Kappos, Ludwig, MD, Freedman, Mark S, MD, Polman, Chris H, MD, Edan, Gilles, MD, Hartung, Hans-Peter, MD, Miller, David H, MD, Montalbán, Xavier, MD, Barkhof, Frederik, MD, Radü, Ernst-Wilhelm, MD, Metzig, Carola, MD, Bauer, Lars, MD, Lanius, Vivian, PhD, Sandbrink, Rupert, MD, Pohl, Christoph, MD

Volltext

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis von Cohen, Jeffrey A, Barkhof, Frederik, Comi, Giancarlo, Hartung, Hans-Peter, Khatri, Bhupendra O, Montalban, Xavier, Pelletier, Jean, Capra, Ruggero, Gallo, Paolo, Izquierdo, Guillermo, Tiel-Wilck, Klaus, de Vera, Ana, Jin, James, Stites, Tracy, Wu, Stacy, Aradhye, Shreeram, Kappos, Ludwig

Volltext

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis von Giovannoni, Gavin, Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Rieckmann, Peter, Sørensen, Per Soelberg, Vermersch, Patrick, Chang, Peter, Hamlett, Anthony, Musch, Bruno, Greenberg, Steven J

Volltext

Sodium intake and multiple sclerosis activity and progression in BENEFIT von Fitzgerald, Kathryn C., Munger, Kassandra L., Hartung, Hans‐Peter, Freedman, Mark S., Montalbán, Xavier, Edan, Gilles, Wicklein, Eva‐Maria, Radue, Ernst‐Wilhelm, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto, Strasser‐Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Štourač, P, Talab, R, Zapletalova, O, Kovařova, I, Medova, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun‐Frenay, C, Gout, O, Kallela, M, Pirttila, T, Ruutiainen, J, Koivisto, K, Villringer, A, Altenkirch, H, Wessel, K, Hartung, H‐P, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoffmann, F, Baum, K, Jung, S, Petereit, H, Reske, D, Sailer, M, Kohler, J, Sommer, N, Hohlfeld, R, Gold, R, Rieckmann, P, Komoly, R, Jakab, G, Csiba, L, Vecsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Cosi, V, Anten, B, Myhr, K‐M, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega‐Jazbec, S, Montalban, X, Arbizu, T, Saiz, A, Barcena, J, Arroyo, R, Fernandez, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, Riordan, J O, Howell, S

Volltext

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score von De Jager, Philip L, MD, Chibnik, Lori B, PhD, Cui, Jing, PhD, Reischl, Joachim, PhD, Lehr, Stephan, PhD, Simon, K Claire, PhD, Aubin, Cristin, BS, Bauer, David, PhD, Heubach, Jürgen F, MD, Sandbrink, Rupert, MD, Tyblova, Michaela, MD, Lelkova, Petra, MD, Havrdova, Eva, MD, Pohl, Christoph, MD, Horakova, Dana, MD, Ascherio, Alberto, MD, Hafler, David A, MD, Karlson, Elizabeth W, MD

Volltext

Randomized study combining interferon and glatiramer acetate in multiple sclerosis von Lublin, Fred D., Cofield, Stacey S., Cutter, Gary R., Conwit, Robin, Narayana, Ponnada A., Nelson, Flavia, Salter, Amber R., Gustafson, Tarah, Wolinsky, Jerry S.

Volltext

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide von Wolinsky, Jerry S, Narayana, Ponnada A, Nelson, Flavia, Datta, Sushmita, O’Connor, Paul, Confavreux, Christian, Comi, Giancarlo, Kappos, Ludwig, Olsson, Tomas P, Truffinet, Philippe, Wang, Lin, Miller, Aaron, Freedman, Mark S

Volltext

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD... von Mikol, Daniel D, MD, Barkhof, Frederik, MD, Chang, Peter, PhD, Coyle, Patricia K, MD, Jeffery, Douglas R, MD, Schwid, Steven R, MD, Stubinski, Bettina, MD, Uitdehaag, Bernard MJ, MD

Volltext

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study von Khatri, Bhupendra, Dr, Barkhof, Frederik, MD, Comi, Giancarlo, MD, Hartung, Hans-Peter, MD, Kappos, Ludwig, MD, Montalban, Xavier, MD, Pelletier, Jean, MD, Stites, Tracy, PhD, Wu, Stacy, MD, Holdbrook, Fred, PhD, Zhang-Auberson, Lixin, MD, Francis, Gordon, MD, Cohen, Jeffrey A, MD

Volltext

Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort von Convery, RS, Bocchetta, M, Greaves, CV, Moore, KM, Cash, DM, Van Swieten, J, Moreno, F, Sanchez-Valle, R, Borroni, B, Laforce, R, Masellis, M, Tartaglia, MC, Graff, C, Galimberti, D, Rowe, JB, Finger, E, Synofzik, M, Vandenberghe, R, de Mendonca, A, Tagliavini, F, Santana, I, Ducharme, S, Butler, C, Gerhard, A, Levin, J, Danek, A, Otto, M, Warren, JD, Rohrer, JD

Volltext

Oral fingolimod (FTY720) in multiple sclerosis : Two-year results of a phase II extension study von O'CONNOR, P, COMI, G, MONTALBAN, X, ANTEL, J, RADUE, E. W, DE VERA, A, POHLMANN, H, KAPPOS, L

Volltext

Interferon β-1b―neutralizing antibodies 5 years after clinically isolated syndrome von HARTUNG, H.-P, FREEDMAN, M. S, SAHAJPAL, V, KNAPPERTZ, V, BECKMANN, K, LANIUS, V, SANDBRINK, R, POHL, C, POLMAN, C. H, EDAN, G, KAPPOS, L, MILLER, D. H, MONTALBAN, X, BARKHOF, F, PETKAU, J, WHITE, R

Volltext

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results von Comi, G., O'Connor, P., Montalban, X., Antel, J., Radue, E-W., Karlsson, G., Pohlmann, H., Aradhye, S., Kappos, L.

Volltext